companyprofile
Actions
Aldawaa Medical Services Co.
- Main Market
- Consumer Staples Distribution & Retail
Stats Overview
-
Prev. Close 82.60
-
Open 82.20
-
High 82.50
-
Low 81.30
-
No. of Trades 1,352
-
Avg. Trade size* 109
-
Volume Traded 147,023
-
Value Traded (SAR) 12,058,663.50
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Last Trade
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select a Maximum of 5 Companies
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions
AnnouncmentandCorporateAction
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
| Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
|---|---|---|---|---|
| 07/11/2024 | 11/11/2024 | 25/11/2024 | Account Transfer | 0.63 |
| 04/08/2024 | 11/08/2024 | 25/08/2024 | Account Transfer | 0.625 |
| 01/01/2024 | 12/02/2024 | 25/02/2024 | Account Transfer | 1.25 |
| 31/08/2023 | 11/09/2023 | 28/09/2023 | Account Transfer | 1.25 |
| 21/03/2023 | 05/04/2023 | 01/05/2023 | Account Transfer | 1.25 |
CompanyProfilev2Financials
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Quarterly
| Balance Sheet | 2023-12-31 | |||
|---|---|---|---|---|
| Total Assets |
4,707,487
|
- | - | - |
| Total Liabilities |
3,394,482
|
- | - | - |
| Total Shareholders Equity (After Deducting the Minority Equity) |
1,313,005
|
- | - | - |
| Total Liabilities and Shareholders Equity |
4,707,487
|
- | - | - |
| Statement of Income | 2023-12-31 | |||
| Total Revenue (Sales/Operating) |
5,741,364
|
- | - | - |
| Net Profit (Loss) before Zakat and Tax |
342,403
|
- | - | - |
| Zakat and Income Tax |
-13,180
|
- | - | - |
| Net Profit (Loss) after Zakat and Tax |
329,223
|
- | - | - |
| Total Comprehensive Income |
430,317
|
- | - | - |
| Profit (Loss) per Share |
3.87
|
- | - | - |
| Cash Flows | 2023-12-31 | |||
| Net Cash From Operating Activities |
725,745
|
- | - | - |
| Net Cash From Investing Activities |
-168,195
|
- | - | - |
| Net Cash From Financing Activities |
-642,196
|
- | - | - |
| Cash and Cash Equivalents, Beginning of the Period |
138,969
|
- | - | - |
| Cash and Cash Equivalents, End of the Period |
54,323
|
- | - | - |
| All Figures in | Thousands | |||
| All Currency In | SAR | |||
| Last Update Date | 2024-03-19 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
| Balance Sheet | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 |
|---|---|---|---|---|
| Total Assets |
5,010,007
|
4,920,549
|
4,860,046
|
4,559,205
|
| Total Liabilities |
3,594,989
|
3,543,331
|
3,561,451
|
3,355,172
|
| Total Shareholders Equity (After Deducting the Minority Equity) |
1,415,018
|
1,377,218
|
1,298,595
|
1,204,033
|
| Total Liabilities and Shareholders Equity |
5,010,007
|
4,920,549
|
4,860,046
|
4,559,205
|
| Statement of Income | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 |
| Total Revenue (Sales/Operating) |
1,626,231
|
1,586,272
|
1,516,420
|
1,438,946
|
| Net Profit (Loss) before Zakat and Tax |
80,023
|
103,913
|
98,793
|
73,819
|
| Zakat and Income Tax |
-4,935
|
-8,035
|
-3,465
|
-2,535
|
| Net Profit (Loss) after Zakat and Tax |
75,088
|
95,878
|
95,328
|
71,283
|
| Total Comprehensive Income |
90,925
|
78,623
|
91,841
|
57,291.6
|
| Profit (Loss) per Share |
0.88
|
1.13
|
1.12
|
0.84
|
| Cash Flows | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 |
| Net Cash From Operating Activities |
528,181
|
348,714
|
232,610
|
587,803
|
| Net Cash From Investing Activities |
-68,749
|
11,988
|
45,309
|
-91,301
|
| Net Cash From Financing Activities |
-481,740
|
-381,765
|
-268,417
|
-574,412
|
| Cash and Cash Equivalents, Beginning of the Period |
54,323
|
54,323
|
54,323
|
138,969
|
| Cash and Cash Equivalents, End of the Period |
32,015
|
33,260
|
63,826
|
61,059
|
| All Figures in | Thousands | Thousands | Thousands | Thousands |
| All Currency In | SAR | SAR | SAR | SAR |
| Last Update Date | 2024-11-05 | 2024-08-04 | 2024-04-30 | 2023-11-28 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
Selling agents in pharmaceuticals. Wholesale of pharmaceutical goods Trade in specialty and healthy foodS pharmacy activities. Pharmaceutical warehouse activities. Retail sale of medical devices, equipment and supplies. Providing delivery services via electronic platforms. Providing marketing services on behalf of others.
Company History
AlDawaa Medical Services Company is a Saudi joint stock listed company, registered under Commercial Registration No 2051025701 dated 09/23/1422H corresponding to 12/08/2001G issued in Khobar Kingdom of Saudi Arabia. The Companys registered address is PO 4326 Khobar 31952 Kingdom of Saudi Arabia. The Company was established in 1991G as a sole proprietorship in the name of Mohammed Saad Al Faraj Commercial Services Est. registered in Khobar under Commercial Registration No. 2051014940 dated 01/16/1412H corresponding to 07/28/1991G. One of its branches called Al-Dawaa Pharmacies the first branch of which was opened in 1993G was converted to a limited liability company in 2001G, with a fully-paid capital of two million Saudi riyals SAR 2000000 divided into two thousand 2000 shares with a fully paid nominal value of one thousand Saudi riyals SAR 1000 per share and it was registered in Khobar under Commercial Registration No. 2051025701 dated 09/23/1422H corresponding to 12/08/2001G, On 10/27/1442H corresponding to 06/08/2021G and pursuant to the Ministerial Resolution No 361 the Company was converted from a limited liability company to a closed joint stock company in the name of Al-Dawaa Medical Services Company with a capital of eight hundred fifty million Saudi Riyals SAR 850000000 divided into eighty-five million 85000000 ordinary shares with a fully paid nominal value of ten Saudi Riyals SAR 10 per share. Since its inception the Companys capital has been increased several times. The capital was first increased by virtue of the partners resolution dated 04/15/1427H corresponding to 05/13/2006G from two million Saudi riyals SAR 2000000 to ten million Saudi riyals SAR 10000000 divided into ten thousand 10000 cash shares with a nominal value of one thousand Saudi riyals SAR 1000 per share. The increase of eight million Saudi riyals SAR 8000000 was covered by transferring such amount from the partners current accounts. On 10/14/1442H corresponding to 05/26/2021G the Companys capital was increased from ten million Saudi riyals SAR 10000000 to eight hundred fifty million Saudi Riyals SAR 850000000 divided into eighty-five million 85000000 ordinary shares with a nominal value of ten Saudi Riyals SAR 10 per share.
Company Bylaws
Equity Profile
- Authorized Capital (SAR) 850,000,000
- Issued Shares 85,000,000
- Paid Capital (SAR) 850,000,000
- Par Value/Share 10
- Paid Up Value/Share 10
Last Update :2022-03-14
Investment limits
here are no investment limits on the company shares as per the amended Rules for Qualified Foreign Financial Institutions Investments in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on company bylaw and the issued instructions by the related regulators and supervisory authorities
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
Mahmoud Marzouk Taha
Company Address:
Khobar -Al Rawabi Dist King Fahd Bin Abdulaziz Road Postal Code 34421 Building No.8501 Ext No 2439- Kingdom of Saudi Arabia
Contact Details:
Telephone:
0568136482
Fax
: 0138670201
Email
: investor.relations@al-dawaa.com.sa
Company Website:
| Name Of Subsidiary | Percentage Of Property | Main Business | Location Of Operation | Country Of Operation |
|---|---|---|---|---|
| Al-Dawaa Medical Services Company FZCO | 100.00% | Marketing activities | UAE | UAE |
| Glanzzen | 100.00% | Marketing activities and health care management consulting activities | UAE | UAE |
| Premier Medical Devices Manufacturing | 100.00% | Manufacture of single-use medical products and consumables, manufacture of medical examination tables and surgical furniture, manufacture of beds with mechanical motion additives, manufacture of medical thermometers, manufacture of respirators and medical anesthesia | KSA | KSA |
| RONZAC CO | 100.00% | Granting marketing licenses for pharmaceutical products, consumer goods and food products | GERMANY | GERMANY |
| Hollinz | 100.00% | Granting marketing licenses for pharmaceutical products, consumer goods and food products | GERMANY | GERMANY |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
- ${title}${badge}